Humanigen, Inc.
HGENQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$23816
P/E Ratio—
52W High—
52W Low—
Humanigen, Inc.（HGENQ）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · HGENQ · 截至 Jun 9, 2026
关键指标
探索 Humanigen, Inc. 数据
hgenq stock data · financials分析师评级与目标价
完整预测Hold6 位分析师is hgenq a buy · hgenq analyst rating
Strong Buy
0
Buy
1
Hold
4
Sell
1
Strong Sell
0
12-Month Price Targethgenq price target · hgenq 12 month forecast
$—Low
$0.00Current
$—Avg Target
$—High
合计: 6 · 买入占比: 16.7%
竞争对手与同行
hgenq competitors#TickerCompanyPriceChangeMkt Cap
#1HGENQHumanigen, Inc.
$0.00+0.00%$23,816#2
CTBOCantabio Pharmaceuticals, Inc.
$1.01+0.00%$22,769#3
DGCRFDiagnocure, Inc.
$0.00+0.00%$21,520#4
GLSHQGelesis Holdings, Inc.
$0.00+0.00%$7,334#5
GNBTGenerex Biotechnology Corporation
$0.00+0.00%$0#6
NAVBNavidea Biopharmaceuticals, Inc.
$0.00-0.00%$10,008股票表现
完整历史1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD-84.62%
1Y-98.78%
5Y-100.00%
关于 Humanigen, Inc.
Humanigen, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies that prevent and manage an overactive immune response. At the forefront of its pipeline is lenzilumab, a mo…
what is humanigen, inc. · hgenq stock overview · humanigen, inc. company profile · who is humanigen, inc. ceo · hgenq OTC · humanigen, inc. headquarters · humanigen, inc. business segments
关于股票概览与关键数据
Humanigen, Inc.（HGENQ）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 31, 2013 在 OTC 上市。截至最近交易日，HGENQ 股价为 $0.00，市值约为 $23,816。过去12个月累计回报 -98.78%，年初至今回报 -84.62%。
常见问题
截至最近一个交易日，Humanigen, Inc.（HGENQ）股价为 $0.00，在 OTC 上市，52周区间为 $1.00 – $5.00。
HGENQ 最新股价HGENQ quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议